Evidence map›Paper›PMID 26735342›Full record

ArticleOncotarget2016

Comprehensive nucleosome mapping of the human genome in cancer progression.

Brooke R Druliner, Daniel Vera, Ruth Johnson, Xiaoyang Ruan, Lynn M Apone, Eileen T Dimalanta, Fiona J Stewart, Lisa Boardman, Jonathan H Dennis

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Long non-coding RNAs: the tentacles of chromatin remodeler complexes.Cellular and molecular life sciences : CMLS · 2021
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Brooke R DrulinerDepartment of Biological Science, Florida State University, Tallahassee, Florida, United States of America.
Daniel VeraDepartment of Biological Science, Florida State University, Tallahassee, Florida, United States of America.
Ruth JohnsonDepartment of Laboratory Medicine and Experimental Pathology, Mayo Clinic, Rochester, Minnesota, United States of America.
Xiaoyang RuanBiomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota, United States of America.
Lynn M AponeNew England Biolabs Inc., Ipswich, Massachusetts, United States of America.
Eileen T DimalantaNew England Biolabs Inc., Ipswich, Massachusetts, United States of America.
Fiona J StewartNew England Biolabs Inc., Ipswich, Massachusetts, United States of America.
Lisa BoardmanDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, United States of America.
Jonathan H DennisDepartment of Biological Science, Florida State University, Tallahassee, Florida, United States of America.
Mayo Clinic · USNew England Biolabs (United States) · USFlorida State University · US

Funding

PILOT AND FEASIBILTY PROGRAMP30DK084567 · NIDDK · MAYO CLINIC ROCHESTER · PI GREGORY J. GORES · 2009 to 2026
$22.2M
Time lapse to cancer: defining transition from polyp to colorectal cancer (PQ14)R01CA170357 · NCI · MAYO CLINIC ROCHESTER · PI BOARDMAN, LISA ALLYN · 2012 to 2016
$2.5M
Chromatin structural changes linking drugs of abuse with HIV reactivationR01DA033775 · NIDA · FLORIDA STATE UNIVERSITY · PI DENNIS, JONATHAN H · 2012 to 2016
$1.8M
NCI NIH HHS R01 CA170357NIDA NIH HHS R01 DA033775NIDDK NIH HHS P30 DK084567
6 · The paper itself

Abstract

Altered chromatin structure is a hallmark of cancer, and inappropriate regulation of chromatin structure may represent the origin of transformation. Important studies have mapped human nucleosome distributions genome wide, but the role of chromatin structure in cancer progression has not been addressed. We developed a MNase-Transcription Start Site Sequence Capture method (mTSS-seq) to map the nucleosome distribution at human transcription start sites genome-wide in primary human lung and colon adenocarcinoma tissue. Here, we confirm that nucleosome redistribution is an early, widespread event in lung (LAC) and colon (CRC) adenocarcinoma. These altered nucleosome architectures are consistent between LAC and CRC patient samples indicating that they may serve as important early adenocarcinoma markers. We demonstrate that the nucleosome alterations are driven by the underlying DNA sequence and potentiate transcription factor binding. We conclude that DNA-directed nucleosome redistributions are widespread early in cancer progression. We have proposed an entirely new hierarchical model for chromatin-mediated genome regulation.

Indexed as

Chromosome MappingGenome, HumanAdenocarcinomaChromatinColonic NeoplasmsDisease ProgressionGene Expression Regulation, NeoplasticHigh-Throughput Nucleotide SequencingHumansLung NeoplasmsNucleosomesChromatinNucleosomescancerchromatinChromosome SectionMNasenucleosomewhole genome

Identifiers

PMID26735342
PMCPMC4924652
OpenAlexW2210604951

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.